Elevate Capital Advisors LLC purchased a new stake in shares of The Clorox Company (NYSE:CLX – Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 5,135 shares of the company’s stock, valued at approximately $834,000.
Other institutional investors also recently bought and sold shares of the company. Brooklyn Investment Group increased its holdings in shares of Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after purchasing an additional 95 shares in the last quarter. Prospera Private Wealth LLC acquired a new stake in Clorox during the third quarter valued at $27,000. Continuum Advisory LLC increased its holdings in Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after buying an additional 138 shares in the last quarter. Carolina Wealth Advisors LLC acquired a new position in shares of Clorox in the third quarter worth about $48,000. Finally, Friedenthal Financial purchased a new stake in shares of Clorox during the 3rd quarter worth about $49,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several brokerages recently weighed in on CLX. StockNews.com lowered Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Royal Bank of Canada restated a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. DA Davidson decreased their target price on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 5th. Barclays boosted their price target on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a report on Wednesday, February 5th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a report on Tuesday, February 4th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $158.21.
Clorox Trading Up 0.6 %
Shares of Clorox stock opened at $148.51 on Monday. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.62. The stock has a market cap of $18.38 billion, a P/E ratio of 40.58, a P/E/G ratio of 2.52 and a beta of 0.42. The stock’s 50 day simple moving average is $161.06 and its 200-day simple moving average is $158.88.
Clorox (NYSE:CLX – Get Free Report) last released its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter last year, the company earned $2.16 EPS. Analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.
Clorox Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 annualized dividend and a dividend yield of 3.29%. Clorox’s dividend payout ratio (DPR) is 133.33%.
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
- Five stocks we like better than Clorox
- Find and Profitably Trade Stocks at 52-Week Lows
- 3 Volatility ETFs to Help You Profit from Market Chaos
- What is a Low P/E Ratio and What Does it Tell Investors?
- Lam Research: Is a NAND Upgrade Cycle the Next Growth Catalyst?
- Stock Analyst Ratings and Canadian Analyst Ratings
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.